Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:35 PM
Ignite Modification Date:
2025-12-24 @ 1:35 PM
NCT ID:
NCT05798195
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of COVID-19 pneumonia；
* 3 to 8 weeks after the onset of the first symptoms of COVID-19 infection;
* Modified Medical Research Council (mMRC) score ⩾2 or hypoxemia;
* Imaging severity assessment of pneumonia: CT severity scores (CTSS):≥5；
* Signed the informed consent.
Exclusion Criteria:
* Participants still admitted to intensive care unit at the time of enrollment;
* Known prior structural lung disease, including pulmonary fibrosis, severe COPD, severe bronchiectasis, and lung destruction;
* Taking glucocorticoids or immunosuppressants because of other chronic diseases;
* Contraindications of glucocorticoid;
* Heart failure(NYHA III or IV);
* Participants with renal replacement therapy;
* Psychiatric disorders or cognitive impairments;
* The expected survival time is less than six months due to diseases other than COVID-19 pneumonia.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05798195
Study Brief:
Protocol Section:
NCT05798195